Press release
04.03.2021 To the attention of interested persons EMA press release: EMA review of regdanvimab for COVID-19 to support national decisions […]
Press release
08.03.2021 To the attention of interested persons EMA press release: EMA issues advice on use of antibody combination (bamlanivimab / […]
Press release
04.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of the Sputnik V COVID-19 vaccine […]
Press release
04.03.2021 To the attention of interested persons The NAMMDR took note of the existence in the public space of some […]
Press release
03.03.2021 To the attention of interested persons EMA press release: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers […]
Important notification
26.02.2021 To the attention of all importers and distributors of medical devices The National Agency for Medicines and Medical Devices […]
Important notification
26.02.2021 To the attention of all importers and distributors of medical devices The National Agency for Medicines and Medical Devices […]
Press release
23.02.2021 To the attention of interested persons EMA press release: EMA starts evaluating use of Veklury in COVID-19 patients not […]
Press release
23.02.2021 To the attention of interested persons EMA press release: Precautionary marketing suspension of thalassaemia medicine Zynteglo download document …
Important notification
22.02.2021 To the attention of Marketing Authorisation Holders UK withdrawal from the European Unit On the 31st December 2020, the […]